Massachusetts Wealth Management / JNJ
Massachusetts Wealth Management’s Johnson & Johnson Position
Does Massachusetts Wealth Management own Johnson & Johnson (JNJ)? Yes — 17.8K shares worth $4M (+1.88% of its 13F portfolio) as of Q1 2026, up from 17.6K shares the prior filed quarter.
Position Value
$4M
Q1 2026
Shares
17.8K
% of Portfolio
+1.88%
Quarters Held
14
currently held
Position History JNJ
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 17.8K | $4M | +1.88% |
| Q4 2025 | 17.6K | $4M | +1.70% |
| Q3 2025 | 17.7K | $3M | +1.63% |
| Q2 2025 | 17.3K | $3M | +1.49% |
| Q1 2025 | 17.2K | $3M | +1.95% |
| Q4 2024 | 17.6K | $3M | +1.57% |
| Q3 2024 | 17.8K | $3M | +1.82% |
| Q2 2024 | 17.6K | $3M | +1.73% |
| Q1 2024 | 17.6K | $3M | +1.96% |
| Q4 2023 | 17.3K | $3M | +2.19% |
| Q3 2023 | 16.1K | $3M | +2.30% |
| Q2 2023 | 15.5K | $3M | +2.45% |
| Q1 2023 | 15.1K | $2M | +2.41% |
| Q4 2022 | 15.5K | $3M | +2.44% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Massachusetts Wealth Management’s full portfolio or all institutional holders of JNJ.